康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09966 康宁杰瑞制药-B

未开盘 09-09 16:08:06

8.450

+0.140

+1.68%

最高8.490	最低8.255	成交量97.60万
今开8.320	昨收8.310	日振幅2.83%
总市值81.80亿	流通市值81.80亿	总股本9.68亿
成交额817.44万	换手率0.10%	流通股本9.68亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":8.45,"timestamp":1788941286009,"preClose":8.31,"halted":0,"volume":976000,"delay":0,"changeRate":0.016847172081828975,"floatShares":968000000,"shares":968000000,"eps":-0.14032295252958565,"marketStatus":"未开盘","change":0.14,"latestTime":"09-09 16:08:06","open":8.32,"high":8.49,"low":8.255,"amount":8174405,"amplitude":0.028279,"askPrice":8.5,"askSize":2000,"bidPrice":8.45,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":-0.21331076692991188,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":0,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.31,"openAndCloseTimeList":[[1788917400000,1788926400000],[1788930000000,1788940800000]],"volumeRatio":0.931653,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"2666690538","title":"康宁杰瑞制药-B(09966)9月9日斥资98.97万港元回购11.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666690538","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666690538?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:57","pubTimestamp":1788955030,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年9月9日斥资98.97万港元回购11.8万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260909/32365182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119552336","title":"康宁杰瑞制药-B：9月9日回购11.80万股，耗资约98.97万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119552336","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119552336?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:26","pubTimestamp":1788953165,"startTime":"0","endTime":"0","summary":"2026年9月9日，康宁杰瑞制药-B在港交所披露翌日披露报表显示，公司于当日于港交所场内回购股份11.80万股，占本次交易前公司已发行股本的0.0122%，回购价格范围在每股8.27港元至8.45港元，总支付对价约98.97万港元。回购完成后，公司已发行股份增减后为967,547,697股，库藏股数量增至6,834,000股。根据公告，此次回购基于2026年6月12日通过的购回授权，公司可回购的股份总数为96,850,669股，已累计回购959,000股，占当日已发行股本总数的约0.099%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B：9月9日回购11.80万股，耗资约98.97万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432730","title":"康宁杰瑞制药-B(09966)9月8日斥资184.99万港元回购22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432730","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665432730?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:26","pubTimestamp":1788866778,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年9月8日斥资184.99万港元回购22万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115594184","title":"康宁杰瑞制药-B 9月8日回购22万股，耗资约184.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115594184","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115594184?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:26","pubTimestamp":1788866761,"startTime":"0","endTime":"0","summary":"2026年9月8日，康宁杰瑞制药-B 发布公告，披露当天于香港联交所场内进行股份购回。根据公告，当日公司回购普通股220,000股，占回购前已发行股本约0.0227%。本次回购的价格每股介于8.345港元至8.53港元，总金额1,849,915港元，折合约184.99万港元。据悉，公司购回授权于2026年6月12日获批，剩余可回购股份总数为96,850,669股。公司确认，本次回购行为符合香港联交所证券上市规则及相关法例的规定。公告由执行董事徐霆签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月8日回购22万股，耗资约184.99万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142581740","title":"康宁杰瑞制药-B 9月7日回购11.5万股，总额约98.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142581740","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142581740?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:21","pubTimestamp":1788776488,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月7日通过香港联交所场内回购股份11.5万股，占公司当日回购前现有已发行股份总数的约0.0119%。此次回购的每股价格介乎每股8.56港元至8.70港元之间，合计涉资约98.92万港元。公司指出已遵守香港联交所证券上市规则及相关法例的规定开展购回交易，并确认本次回购后在30天内不会在未获香港联交所批准的情况下发行新股或出售、转让任何库存股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月7日回购11.5万股，总额约98.92万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665441315","title":"康宁杰瑞制药-B(09966)9月7日斥资98.92万港元回购11.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665441315","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665441315?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:17","pubTimestamp":1788776264,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年9月7日斥资98.92万港元回购11.5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B(09966)9月7日斥资98.92万港元回购11.5万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315426","title":"康宁杰瑞制药-B(09966.HK)9月7日斥资98.92万港元回购11.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665315426?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:17","pubTimestamp":1788776264,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147127902","title":"康宁杰瑞制药-B回购5.60万股股份，总额约49.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147127902","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147127902?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:56","pubTimestamp":1788522985,"startTime":"0","endTime":"0","summary":"2026年9月4日，康宁杰瑞制药-B发布公告，称于当日通过香港联交所场内回购股份。本次回购数量为56,000股，占该次股份变动前公司已发行股本约0.0058%。回购价格介于每股8.75港元至8.80港元，合计涉资约49.24万港元。公告显示，该公司曾于2026年6月12日通过购回授权，获准最多回购96,850,669股。截至目前，公司已购回506,000股，占上述获授权时已发行股份总数的约0.0522%。公司并确认已遵守香港联交所证券上市规则及相关法律法规要求。本公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康宁杰瑞制药-B回购5.60万股股份，总额约49.24万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664331822","title":"康宁杰瑞制药-B(09966)9月4日耗资49.243万港元回购5.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664331822","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664331822?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:56","pubTimestamp":1788522985,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)公布，2026年9月4日耗资49.243万港元回购5.6万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103831119","title":"康宁杰瑞制药-B更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103831119","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103831119?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:46","pubTimestamp":1788518814,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月4日披露截至2026年8月31日止的股份变动月报表，显示公司注册股本与已发行股份总数在本月整体保持稳定。根据公告，公司法定/注册股本维持25,100,000,000股普通股，面值为每股USD 0.000002，总额USD 50,200，与上月底持平。本月未因期权行使而发行新股。购回信息显示，公司于2026年8月31日以每股平均价格港币8.901元回购普通股110,000股，并以库存股份形式持有，尚未注销。本次月报由公司执行董事徐霆签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238859","title":"【券商聚焦】交银国际：医药行业收入稳健增长 多重利好推动盈利表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238859","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238859?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:00","pubTimestamp":1788483634,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，1H26港股/A股医药行业整体收入增长4.7%/3.2%。创新药产业链增速领跑行业，服务板块复苏：1）港股/A股CXO收入整体增长29.2%/25.3%，（扣非）净利润增长23.4%/67.6%，在各子板块中增速最快，行业整体景气度和订单需求处于高位。2）核心成药板块收入增长17.8%/3.4%、利润增长62.7%/35.0%。其中生物药增速远超化药，在板块收入中的占比也进一步提升。3）医院、器械、诊断、疫苗等板块业绩有复苏趋势。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","IE00B0JY6N72.USD","01951","KURE","09926","LU0315179316.USD","01276","LU0039217434.USD","03329","06160","02269","03759","LU1242518857.USD","HK0000320264.USD","01952","HK0000306685.HKD","02162","LU0327786744.USD","02268","BK1161","BK1589","01530","02596","BK1515","01093","06821","IE00B543WZ88.USD","LU0588546209.SGD","09966","BK1209","SG9999004220.SGD","06990","03692","LU0307460666.USD","02096","LU1251922891.USD","06996","KCE","LU2543165471.USD","LU1880383366.USD","LU0348783233.USD","IE00B5MMRT66.SGD","01177","06078","02273","LU1152091168.USD","LU0856984785.SGD","09996","01548","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145148824","title":"康宁杰瑞制药-B回购11万股股份，耗资约97.39万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145148824","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145148824?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:46","pubTimestamp":1788435978,"startTime":"0","endTime":"0","summary":"2026年9月3日，康宁杰瑞制药-B公告披露，公司于当日在香港联交所场内回购普通股11.00万股，占该次回购前公司已发行股本约0.0114%。本次回购的每股价格介于每股8.80港元至8.90港元之间，涉资总额约97.39万港元。回购完成后，公司已发行股本为968,056,697股，库藏股增至6,325,000股。公司表示，此次回购授权于2026年6月12日通过，已获准回购股份上限为96,850,669股。公司同时确认，本次在香港联交所进行的股份购回符合香港联交所证券上市规则及相关法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购11万股股份，耗资约97.39万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103198882","title":"康宁杰瑞制药-B：9月2日回购115,000股，耗资约98.58万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103198882","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103198882?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:31","pubTimestamp":1788359474,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月2日宣布回购公司股份。根据公告，当日于香港联交所场内共回购115,000股普通股股份，占回购前公司已发行股本约0.0119%。回购价格介于每股8.43港元至8.62港元之间，合计使用资金985,800港元。本次股份回购完成后，公司已发行股份数量减少至968,166,697股，库存股份增至6,215,000股，总已发行股票数仍为974,381,697股。公司同时确认本次回购时间与程序均符合香港联交所主板上市规则及相关法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B：9月2日回购115,000股，耗资约98.58万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664292817","title":"康宁杰瑞制药-B(09966.HK)9月2日耗资98.58万港元回购11.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664292817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664292817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:27","pubTimestamp":1788359269,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181267403","title":"康宁杰瑞制药-B 9月1日回购11.5万股股份，耗资约97.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181267403","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181267403?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:41","pubTimestamp":1788262917,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月1日发布公告，披露当日于香港联交所回购普通股11.5万股，占该等回购前已发行股本0.0119%，回购价格介乎每股8.48港元至8.535港元之间，总计耗资约97.90万港元。根据此前于2026年6月12日通过的回购授权，公司可回购股份总数为96,850,669股，截至目前已累计回购股份22.5万股，约占回购授权通过当日已发行股本的0.0232%。公司同时公布，根据香港联交所主板上市规则相关要求，本次股份购回程序合规有效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月1日回购11.5万股股份，耗资约97.90万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130109343","title":"康宁杰瑞制药-B回购11万股股份，耗资约97.91万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130109343","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130109343?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:55","pubTimestamp":1788180952,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B（09966）于2026年8月31日公布翌日披露报表，披露其于当天在香港联交所场内回购普通股股份。根据公告显示，公司此次合计回购股份数量为110,000股，占回购前已发行股本约0.0114%。回购价格介乎每股8.825港元至8.92港元，合计涉资约97.91万港元。\n回购完成后，公司已发行股份总数变更为968,396,697股，公司库藏股数量为5,985,000股。公告同时显示，公司于2026年6月12日通过了回购授权，目前尚余可回购股份96,850,669股。公司确认已遵守香港联合交易所主板上市规则及其他相关法律法规。\n本次公告由执行董事徐霆签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购11万股股份，耗资约97.91万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003791","title":"康宁杰瑞制药-B(09966.HK)8月31日斥资97.91万港元回购11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003791","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663003791?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:47","pubTimestamp":1788180441,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663109093","title":"康宁杰瑞制药-B(09966.HK)拟在公开市场购回股份 金额最高为8000万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663109093","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663109093?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:57","pubTimestamp":1787936222,"startTime":"0","endTime":"0","summary":"格隆汇8月29日丨康宁杰瑞制药-B(09966.HK)宣布，根据董事获授出的一般授权(由股东于2026年6月12日举行的公司股东周年大会上批准)，董事会于2026年8月28日决议不时自公开市场购回公司普通股，购回股份的金额最高为8000万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260829/32352919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276094","title":"康宁杰瑞制药-B(09966.HK)拟回购最高8000万港元的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662276094?lang=zh_cn&edition=full","pubTime":"2026-08-28 23:25","pubTimestamp":1787930748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198080615","title":"康宁杰瑞制药-B（09966）拟斥资最高80百万元港元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1198080615","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198080615?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:03","pubTimestamp":1787925788,"startTime":"0","endTime":"0","summary":"2026年8月28日，康宁杰瑞制药-B发布自愿公告称，公司董事会已根据2026年6月12日股东周年大会授出的股份购回授权，通过决议批准于公开市场回购公司普通股，回购金额上限为80百万元港元。资金来源方面，公司计划以现有可用现金支付本次建议回购所需资金。公司将根据市场情况及资本管理需求，决定被回购股份是注销还是作为库存股份持有。公司表示，回购的时间、数量及价格将视市场情况而定，不保证一定实施或完成任何股份回购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":-0.014},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.1736},{"period":"6month","weight":-0.0174},{"period":"1year","weight":-0.2006},{"period":"ytd","weight":-0.1378}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.0075},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司的内部管线由处于不同研发阶段的抗体偶联药物（ADC）、单克隆抗体及双特异性抗体肿瘤药物组成。该公司的产品管线包括KN046（PD-L1/CTLA-4双特异性抗体）、KN026（抗HER2双特异性抗体）、KN035（皮下注射PD-L1）、JSKN003（HER2双表位ADC）、JSKN016（HER3/TROP2双特异性抗体ADC）、JSKN033（JSKN003和KN035 的皮下复方制剂）等，用于1L sq NSCLC、1L HER2+乳腺癌、1L胆道癌、晚期实体瘤、HER2表达实体瘤等适应症。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.117313},{"month":2,"riseRate":0.571429,"avgChangeRate":0.192959},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.039472},{"month":4,"riseRate":0.857143,"avgChangeRate":0.098183},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.031094},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.059361},{"month":7,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":8,"riseRate":0.428571,"avgChangeRate":0.047929},{"month":9,"riseRate":0.285714,"avgChangeRate":0.127495},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.030396},{"month":11,"riseRate":0.5,"avgChangeRate":0.042537},{"month":12,"riseRate":0.5,"avgChangeRate":-0.017716}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}